Atlas Trials

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21

Clinical trial NCT00583752 · COMPLETED

Trial details

NCT number
NCT00583752
Sponsor
David M Lubaroff
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Prostate Cancer
Start date
2007-12-01
Primary completion
2020-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.